University of Missouri School of Medicine Researchers Further Understanding of Acute Lymphoblastic Leukemia (Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed KMT2A-rearranged acute ...)

Prensa/medios de comunicación: !!!Research

Períodojul. 3 2024

Cobertura de los medios

1

Cobertura de los medios

  • NombreUniversity of Missouri School of Medicine Researchers Further Understanding of Acute Lymphoblastic Leukemia (Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed KMT2A-rearranged acute ...)
    Nombre/canal del medio de comunicaciónGenomics & Genetics Daily
    País/TerritorioEstados Unidos
    Fecha3/7/24
    PersonasMeenakshi Devidas
Ver todos 1
Ver menos